Table 1: Patient
characteristics and operative details.
|
Indicator |
ERAS group (n = 45) |
Control group (n = 44) |
P |
|
Age (Ме) |
70
(63.75; 80.25) |
70.5
(61; 78.75) |
0.515 |
|
Sex, n (%) |
|
|
|
|
Male |
19
(42.2) |
20
(45.5) |
0.94 |
|
Female |
26
(57.8) |
24
(54.5) |
0.973 |
|
Location
of cancer, n
(%) |
|
||
|
Cecum |
7 (15.5) |
6 (13.6) |
0.923 |
|
Ascending |
4 (8.9) |
3 (6.8) |
0.84 |
|
Hepatic flexure |
1 (2.2) |
2 (4.6) |
0.55 |
|
Transverse |
4 (8.9) |
3 (6.8) |
0.84 |
|
Splenic flexure |
5 (11.1) |
4 (9.1) |
0.887 |
|
Descending |
4 (8.9) |
5 (11.4) |
0.832 |
|
Sigmoid |
12 (26.7) |
10 (22.7) |
0.91 |
|
Recto-sigmoid |
8 (17.8) |
11 (25) |
0.778 |
|
Types
of surgery, n (%) |
|
||
|
Right hemicolectomy |
12 (26.7) |
13 (29.5) |
0.927 |
|
Left obstructive resection (of Hartmannˋs
procedure type) |
33 (73.3) |
31 (70.5) |
0.987 |
|
Duration
of obstruction, day (SD) |
3.8 ± 1.2 |
3.6 ± 1.5 |
0.45 |
|
Operative
duration, min (Ме) |
175
(140; 222.5) |
200
(151.25; 240) |
0.822 |
|
Anesthesia duration,
min (Ме) |
222.5
(183.75; 280) |
260
(205; 290) |
0.71 |
|
ASA, n
(%) |
|
|
|
|
≤
3 |
27
(60) |
24
(54.5) |
0.95 |
|
>
3 |
18
(40) |
20
(45.5) |
0.91 |
|
CR-Possum |
|
|
|
|
Morbidity,
% (Ме) |
52.5
(29.5; 71.75) |
45
(37; 64.5) |
0.229 |
|
Mortality,
% (Ме) |
19.5
(10; 33.75) |
21.5
(14.5; 34.5) |
0.62 |
|
Co-morbidity index (Charlson),
(SD) |
8.13 ± 2.92 |
7.96 ± 2.15 |
0.26 |